Feed Preview

Fast Growing

Hepatocellular Carcinoma (Keystone)

Hepatocellular Carcinoma (Keystone) diagram by undefined

Type II DNA topoisomerase (TOP2) generate double-stranded breaks in DNA to facilitate replication and transcription. Recent research on the protein interactions of TOP2 reveal associations with multiple regulatory elements is furthering our understanding of gene expression. Follow the latest research on TOP2 and enhancer function in hepatocellular carcinoma with this feed.

Top 20 most recent papers
Biochemical and Biophysical Research Communications

Histone deacetylases up-regulate C/EBPα expression through reduction of miR-124-3p and miR-25 in hepatocellular carcinoma

Biochemical and Biophysical Research CommunicationsMay 17, 2019
Xiao-Xiao HuGuo-Dong Lu
International Journal of Molecular Sciences

Synthesis and Evaluation of Anticancer Activity of New 4-Acyloxy Derivatives of Robustic Acid

International Journal of Molecular SciencesNovember 14, 2019
Rui ChenYan Liang
International Journal of Medical Sciences

Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis

International Journal of Medical SciencesJuly 25, 2019
Xuan WuChaoyang Zhang
1
10
Cellular and Molecular Gastroenterology and Hepatology

The Dynamic Chromatin Architecture of the Regenerating Liver

Cellular and Molecular Gastroenterology and HepatologyOctober 21, 2019
Amber W. WangKlaus H. Kaestner
11
2
9
Molecular Therapy : the Journal of the American Society of Gene Therapy

Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice

Molecular Therapy : the Journal of the American Society of Gene TherapyMarch 11, 2019
Jiehua ZhouJohn J Rossi
15
10

See more papers from this feed

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2020 Meta ULC. All rights reserved
/feed-previews/hepatocellular-carcinoma-keystone/063ab167-b1e4-4cc1-be86-3f6d92055d6d